Access Bio Financials
| 950130 Stock | KRW 5,100 10.00 0.20% |
Access |
Understanding current and past Access Bio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Access Bio's financial statements are interrelated, with each one affecting the others. For example, an increase in Access Bio's assets may result in an increase in income on the income statement.
Please note, the presentation of Access Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Access Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Access Bio's management manipulating its earnings.
Access Bio Stock Summary
Access Bio competes with Aprogen Healthcare, Homecast CoLtd, Nable Communications, Vivozon Healthcare, and Infinitt Healthcare. Access Bio, Inc. researches, develops, and manufactures in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR8840090003 |
| Business Address | 65 Clyde Road, |
| Sector | Healthcare |
| Industry | Health Care Equipment & Supplies |
| Benchmark | Dow Jones Industrial |
| Website | www.accessbiodiagnostics.net |
| Phone | 732 873 4040 |
| Currency | KRW - South Korean Won |
You should never invest in Access Bio without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Access Stock, because this is throwing your money away. Analyzing the key information contained in Access Bio's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Access Bio Key Financial Ratios
Access Bio's financial ratios allow both analysts and investors to convert raw data from Access Bio's financial statements into concise, actionable information that can be used to evaluate the performance of Access Bio over time and compare it to other companies across industries.Access Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Access Bio's current stock value. Our valuation model uses many indicators to compare Access Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Access Bio competition to find correlations between indicators driving Access Bio's intrinsic value. More Info.Access Bio is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The ratio of Return On Equity to Return On Asset for Access Bio is about 311.57 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Access Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Access Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Access Bio Systematic Risk
Access Bio's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Access Bio volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Access Bio correlated with the market. If Beta is less than 0 Access Bio generally moves in the opposite direction as compared to the market. If Access Bio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Access Bio is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Access Bio is generally in the same direction as the market. If Beta > 1 Access Bio moves generally in the same direction as, but more than the movement of the benchmark.
Access Bio March 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Access Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Access Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of Access Bio based on widely used predictive technical indicators. In general, we focus on analyzing Access Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Access Bio's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.54 | |||
| Information Ratio | 0.0267 | |||
| Maximum Drawdown | 27.15 | |||
| Value At Risk | (4.08) | |||
| Potential Upside | 4.43 |
Complementary Tools for Access Stock analysis
When running Access Bio's price analysis, check to measure Access Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Access Bio is operating at the current time. Most of Access Bio's value examination focuses on studying past and present price action to predict the probability of Access Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Access Bio's price. Additionally, you may evaluate how the addition of Access Bio to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |